Illinois Municipal Retirement Fund lifted its position in Maximus, Inc. (NYSE:MMS - Free Report) by 27.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 32,311 shares of the health services provider's stock after purchasing an additional 7,038 shares during the quarter. Illinois Municipal Retirement Fund owned about 0.06% of Maximus worth $2,203,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Vanguard Group Inc. lifted its holdings in shares of Maximus by 3.2% during the 4th quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider's stock worth $488,829,000 after acquiring an additional 205,564 shares during the last quarter. Mackenzie Financial Corp lifted its position in Maximus by 2.0% in the 4th quarter. Mackenzie Financial Corp now owns 2,782,150 shares of the health services provider's stock worth $207,687,000 after buying an additional 55,583 shares during the last quarter. Dimensional Fund Advisors LP boosted its stake in Maximus by 14.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider's stock worth $105,001,000 after buying an additional 177,075 shares in the last quarter. Fuller & Thaler Asset Management Inc. grew its position in Maximus by 7.4% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider's stock valued at $92,188,000 after acquiring an additional 84,835 shares during the last quarter. Finally, Janus Henderson Group PLC raised its stake in shares of Maximus by 2.0% during the fourth quarter. Janus Henderson Group PLC now owns 1,186,150 shares of the health services provider's stock worth $88,546,000 after acquiring an additional 22,711 shares in the last quarter. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Maximus Trading Down 0.5%
Shares of NYSE MMS traded down $0.38 during trading hours on Thursday, hitting $72.06. The company's stock had a trading volume of 224,629 shares, compared to its average volume of 573,791. Maximus, Inc. has a 12 month low of $63.77 and a 12 month high of $93.97. The stock has a market cap of $4.06 billion, a price-to-earnings ratio of 14.33 and a beta of 0.61. The company has a debt-to-equity ratio of 0.87, a quick ratio of 1.84 and a current ratio of 1.84. The business has a 50-day simple moving average of $71.02 and a 200-day simple moving average of $70.93.
Maximus (NYSE:MMS - Get Free Report) last announced its earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 23.37% and a net margin of 5.56%. The firm's revenue for the quarter was up 1.0% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.57 earnings per share. On average, analysts anticipate that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th were given a dividend of $0.30 per share. The ex-dividend date was Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.67%. Maximus's payout ratio is 23.86%.
Analyst Upgrades and Downgrades
Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.
Read Our Latest Analysis on MMS
Insider Buying and Selling at Maximus
In other news, Director Gayathri Rajan sold 7,913 shares of the firm's stock in a transaction that occurred on Friday, May 30th. The stock was sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the transaction, the director owned 14,205 shares in the company, valued at $1,028,157.90. This trade represents a 35.78% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 1.60% of the company's stock.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
See Also

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.